ACTH 1-24 inhibits proliferation of adrenocortical tumors in vivo

European Journal of Endocrinology

Volumn 153, Issue 3, 2005, Pages 435-444

  Zwermann, Oliver ^b   Schulte, Dominik M ^a   Reincke, Martin ^b   Beuschlein, Felix ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MELANOCORTIN 2 RECEPTOR; TETRACOSACTIDE; TETRACOSACTIDE ZINC PHOSPHATE;

ADRENAL CORTEX TUMOR; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LOW DRUG DOSE; MALE; MOUSE; MOUSE STRAIN; NICK END LABELING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLOW RELEASE FORMULATION; TUMOR CELL; TUMOR VOLUME; WESTERN BLOTTING;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL HYPERFUNCTION; ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CORTICOSTERONE; COSYNTROPIN; DELAYED-ACTION PREPARATIONS; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICE; ORGAN SIZE; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, MELANOCORTIN, TYPE 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSFECTION;

EID: 26244448082     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01983     Document Type: Article

References (51)

1. Mountjoy KG, Robbins LS, Mortrud MT & Cone RD. The cloning of a family of genes that encode the melanocortin receptors. Science 1992 257 1248-1251.
2. Lotfi CF, Todorovic Z, Armelin HA & Schimmer BP. Unmasking a growth-promoting effect of the adrenocorticotropic hormone in Y1 mouse adrenocortical tumor cells. Journal of Biological Chemistry 1997 272 29886-29891.
3. Gallo-Payet N & Payet MD. Mechanism of action of ACTH: beyond cAMP. Microsc Res Tech 2003 61 275-287.
4. Allolio B, Hahner S, Weismann D & Fassnacht M. Management of adrenocortical carcinoma. Clinical Endocrinology 2004 60 273-287.
5. Latronico AC, Reincke M, Mendonca BB, Arai K, Mora P, Allolio B, Waichenberg BL, Chrousos GP & Tsigos C. No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms. Journal of Clinical Endocrinology and Metabolism 1995 80 875-877.
6. Light K, Jenkins PJ, Weber A, Perrett C, Grossman A, Pistorello M, Asa SL, Clayton RN & Clark AJ. Are activating mutations of the adrenocorticotropin receptor involved in adrenal cortical neoplasia? Life Sciences 1995 56 1523-1527.
7. Reincke M, Karl M, Travis W & Chrousos GP. No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms. Journal of Clinical Endocrinology and Metabolism 1993 77 1419-1422.
8. Fragoso MC, Domenice S, Latronico AC, Martin RM, Pereira MA, Zerbini MC, Lucon AM & Mendonca BB. Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. Journal of Clinical Endocrinology and Metabolism 2003 88 2147-2151.
9. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E & Bourne HR. Two G protein oncogenes in human endocrine tumors. Science 1990 249 655-659.
10. Reincke M, Beuschlein F, Menig G, Hofmockel G, Arlt W, Lehmann R, Karl M & Allolio B. Localization and expression of adrenocorticotropic hormone receptor mRNA in normal and neoplastic human adrenal cortex. Journal of Endocrinology 1998 156 415-423.
11. Reincke M, Beuschlein F, Latronico AC, Arlt W, Chrousos GP & Allolio B. Expression of adrenocorticotrophic hormone receptor mRNA in human adrenocortical neoplasms: correlation with P450scc expression. Clinical Endocrinology 1997 46 619-626.
12. Reincke M, Mora P, Beuschlein F, Arlt W, Chrousos GP & Allolio B. Deletion of the adrenocorticotropin receptor gene in human adrenocortical tumors: implications for tumorigenesis. Journal of Clinical Endocrinology and Metabolism 1997 82 3054-3058.
13. Clark AJ & Weber A. Adrenocorticotropin insensitivity syndromes. Endocrine Reviews 1998 19 828-843.
14. Cater DB & Stack-Dunne MP. The histological changes in the adrenal of the hypophysectomised rat after treatment with pituitary preparations. Journal of Pathology and Bacteriology 1953 66 119-133.
15. Mazzocchi G, Malendowicz LK, Rebuffat P, Robba C, Gottardo G & Nussdorfer GG. Short- and long-term effects of ACTH on the adrenal zona glomerulosa of the rat. A coupled stereological and enzymological study. Cell and Tissue Research 1986 243 303-310.
16. Coll AP, Challis BG, Yeo GS, Snell K, Piper SJ, Halsall D, Thresher RR & O'Rahilly S. The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin. Endocrinology 2004 145 4721-4727.
17. Masui H & Garren LD. On the mechanism of action of adrenocorticotropic hormone. The stimulation of thymidine kinase activity with altered properties and changed subcellular distribution. Journal of Biological Chemistry 1971 246 5407-5413.
18. Masui H & Garren LD. On the mechanism of action of adrenocorticotropic hormone. Stimulation of deoxyribonucleic acid polymerase and thymidine kinase activities in adrenal glands. Journal of Biological Chemistry 1970 245 2627-2632.
19. Payet N, Lehoux JG & Isler H. Effect of ACTH on the proliferative and secretory activities of the adrenal glomerulosa. Acta Endocrinologica 1980 93 365-374.
20. Estivariz FE, Iturriza F, McLean C, Hope J & Lowry PJ. Stimulation of adrenal mitogenesis by N-terminal proopiocortin peptides. Nature 1982 297 419-422.
21. Estivariz FE, Carino M, Lowry PJ & Jackson S. Further evidence that N-terminal proopiomelanocortin peptides are involved in adrenal mitogenesis. Journal of Endocrinology 1988 116 201-206.
22. Lowry PJ, Silas L, McLean C, Linton EA & Estivariz FE. Pro-gammamelanocytestimulating hormone cleavage in adrenal gland undergoing compensatory growth. Nature 1983 306 70-73.
23. Bicknell AB, Lomthaisong K, Woods RJ, Hutchinson EG, Bennett HP, Gladwell RT & Lowry PJ. Characterization of a serine protease that cleaves pro-gammamelanotropin at the adrenal to stimulate growth. Cell 2001 105 903-912.
24. Masui H & Garren LD. Inhibition of replication in functional mouse adrenal tumor cells by adrenocorticotropic hormone mediated by adenosine 3′:5′-cyclic monophosphate. PNAS 1971 68 3206-3210.
25. Weidman RE & Gill GN. Differential effects of ACTH or 8-Dr-cAMP on growth and replication in a functional adrenal tumor cell line. Journal of Cellular Physiology 1977 90 91-103.
26. Morera AM & Saez JM. In vitro mitogenic and steroidogenic effects of ACTH analogues on an adrenal tumor cell line (Y-1). Experimental Cell Research 1980 127 446-451.
27. Ramachandran J & Suyama AT. Inhibition of replication of normal adrenocortical cells in culture by adrenocorticotropin. PNAS 1975 72 113-117.
28. Gospodarowicz D & Handley HH. Stimulation of division of Y1 adrenal cells by a growth factor isolated from bovine pituitary glands. Endocrinology 1975 97 102-107.
29. Hornsby PJ & Gill GN. Hormonal control of adrenocortical cell proliferation. Desensitization to ACTH and interaction between ACTH and fibroblast growth factor in bovine adrenocortical cell cultures. Journal of Clinical Investigation 1977 60 342-352.
30. Simonian MH & Gill GN. Regulation of the fetal human adrenal cortex: effects of adrenocorticotropin on growth and function of monolayer cultures of fetal and definitive zone cells. Endocrinology 1981 108 1769-1779.
31. Armato U, Andreis PG, Draghi E & Meneghelli V. Primary tissue culture of normal adult human decapsulated adrenal cortex: radioautographic studies on the metabolic effects of ACTH1-24. Hormone Research 1975 6 105-115.
32. Armato U, Nussdorfer GG, Neri G, Draghi E, Andreis PG, Mazzocchi G & Mantero F. Effects of ACTH and 3′,5′-cyclic purine nucleotides on the morphology and metabolism of normal adult human adrenocortical cells in primary tissue culture. Cell and Tissue Research 1978 190 187-205.
33. Menapace L, Armato U & Whitfield JF. The effects of corticotrophin (ACTH1-24), cyclic AMP and TPA (12-O-tetradecanoyl phorbol-13-acetate) on DNA replication and proliferation of primary rabbit adrenocortical cells in a synthetic medium. Biochemical and Biophysical Research Communication 1987 148 1295-1303.
34. Arola J, Heikkila P & Kahri AI. Biphasic effect of ACTH on growth of rat adrenocortical cells in primary culture. Cell and Tissue Research 1993 271 169-176.
35. Kimura E, Sonobe MH, Armelin MC & Armelin HA. Induction of FOS and JUN proteins by adrenocorticotropin and phorbol ester but not by 3′,5′-cyclic adenosine monophosphate derivatives. Molecular Endocrinology 1993 7 1463-1471.
36. Viard I, Penhoat A, Ouali R, Langlois D, Begeot M & Saez JM. Peptide hormone and growth factor regulation of nuclear proto-oncogenes and specific functions in adrenal cells. Journal of Steroid Biochemistry and Molecular Biology 1994 50 219-224.
37. Schimmer BP, Kwan WK, Tsao J & Qiu R. Adrenocorticotropin-resistant mutants of the Y1 adrenal cell line fail to express the adrenocorticotropin receptor. Journal of Cellular Physiology 1995 163 164-171.
38. Qiu R, Tsao J, Kwan WK & Schimmer BP. Mutations to forskolin resistance result in loss of adrenocorticotropin receptors and consequent reductions in levels of G protein alpha-subunits. Molecular Endocrinology 1996 10 1708-1718.
39. Boston BA & Cone RD. Characterization of melanocortin receptor subtype expression in murine adipose tissues and in the 3T3-L1 cell line. Endocrinology 1996 137 2043-2050.
40. Zwermann O, Beuschlein F, Klink A, Stahl M & Reincke M. The role of the ACTH receptor in adrenal tumors: identification of a novel microsatellite marker. Hormone and Metabolic Research 2004 36 406-410.
41. Naville D, Barjhoux L, Jaillard C, Faury D, Despert F, Esteva B, Durand P, Saez JM & Begeot M. Demonstration by transfection studies that mutations in the adrenocorticotropin receptor gene are one cause of the hereditary syndrome of glucocorticoid deficiency. Journal of Clinical Endocrinology and Metabolism 1996 81 1442-1448.
42. Weber A, Kapas S, Hinson J, Grant DB, Grossman A & Clark AJ. Functional characterization of the cloned human ACTH receptor: impaired responsiveness of a mutant receptor in familial glucocorticoid deficiency. Biochemical and Biophysical Research Communications 1993 197 172-178.
43. Noon LA, Franklin JM, King PJ, Goulding NJ, Hunyady L & Clark AJ. Failed export of the adrenocorticotrophin receptor from the endoplasmic reticulum in non-adrenal cells: evidence in support of a requirement for a specific adrenal accessory factor. Journal of Endocrinology 2002 174 17-25.
44. Metherell LA, Chapple JP, Cooray S, David A, Becker C, Ruschendorf F, Naville D, Begeot M, Khoo B, Nurnberg P, Huebner A, Cheetham ME & Clark AJ. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nature Genetics 2005 37 166-170.
45. Elias LL, Huebner A, Pullinger GD, Mirtella A & Clark AJ. Functional characterization of naturally occurring mutations of the human adrenocorticotropin receptor: poor correlation of phenotype and genotype. Journal of Clinical Endocrinology and Metabolism 1999 84 2766-2770.
46. Frigeri C, Tsao J, Cordova M & Schimmer BP. A polymorphic form of steroidogenic factor-1 is associated with adrenocorticotropin resistance in y1 mouse adrenocortical tumor cell mutants. Endocrinology 2002 143 4031-4037.
47. Schimmer BP, Cordova M, Tsao J & Frigeri C. A polymorphic form of steroidogenic factor 1 associated with ACTH receptor deficiency in mouse adrenal cell mutants. Annals of the New York Academy of Sciences 2003 994 147-153.
48. Gallo-Payet N & Escher E. Adrenocorticotropin receptors in rat adrenal glomerulosa cells. Endocrinology 1985 117 38-46.
49. Abdel-Malck ZA. Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cellular and Molecular Life Sciences 2001 58 434-441.
50. Fassnacht M, Hahner S, Hansen IA, Kreutzberger T, Zink M, Adermann K, Jakob F, Troppmair J & Allolio B. N-terminal proopiomelanocortin acts as a mitogen in adrenocortical tumor cells and decreases adrenal steroidogenesis. Journal of Clinical Endocrinology and Metabolism 2003 88 2171-2179.
51. Betz MJ, Shapiro I, Fassnacht M, Hahner S, Reincke M & Beuschlein F. Peroxisome proliferator activated receptor gamma (PPARγ) agonists suppress adrenocortical tumor cell proliferation and induce differentiation. Journal of Clinical Endocrinology and Metabolism 2005 90 3886-3896.